Search

everythinglearnresearchcommunity

for

Search:↓

A mix of Polygonatum sibiricum and Nelumbinis semen may ease menopause symptoms with fewer side effects.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

The patient's long-term symptoms were due to Sheehan's syndrome, which improved with hormone therapy.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Treatments for hair loss include estrogen therapy and special shampoos.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Monitoring for adverse effects in clinical treatments is crucial.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.